April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. • APP could not provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=842 Source: www.ashp.org Leflunomide Tablets March 9, 2012 Products Affected - Description Leflunomide tablets, Sandoz 10 mg, 30 count (NDC 00781-5056-31) 20 mg, 30 count (NDC 00781-5057-31) Leflunomide tablets, Teva 20 mg, 30 count (NDC 00093-0174-56) Reason for the Shortage Apotex relaunched leflunomide tablets in August 2011. Teva had leflunomide tablets on shortage due to unavailability of raw material. Sandoz had leflunomide tablets on shortage due to increased demand and delay of raw material. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=711 Source: www.ashp.org Calcitriol Injection March 9, 2012 Products Affected - Description Calcijex 1 mcg/mL Injection, Abbott 1 mL ampule, 100 count (NDC 00074-8110-31) Calcitriol 1 mcg/mL Injection, American Regent 1 mL ampule, 25 count (NDC 00517-0132-25) Calcitriol 1 mcg/mL Injection, West-Ward 1 mL ampule, 5 count (NDC 00143-9728-05) - discontinued Reason for the Shortage Akorn has increased production of calcitriol injection due to increased demand for the product. American Regent had temporarily suspended manufacture of most drug products including calcitriol injection in April, 2011. American Regent resumed manufacturing in Shirley, New York in early-May, 2011. West-Ward discontinued their calcitriol injection in May, 2011. Calcitriol capsule and oral solution presentations are available from multiple manufacturers. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=776 Source: www.ashp.org Triamterene and Hydrochlorothiazide Capsules and Tablets March 12, 2012 Products Affected - Description Triamterene and Hydrochlorothiazide capsules, Sandoz 37.5 mg/25 mg, 100 count (NDC 00781-2074-01) 40
37.5 mg/25 mg, 1000 count (NDC 00781-2074-10) 50 mg/25 mg, 100 count (NDC 00781-2715-01) 37.5 mg/25 mg, 500 count (NDC 00781-1123-05) Triamterene and Hydrochlorothiazide tablets, Mylan 75 mg/50 mg, 100 count (NDC 00378-1355-01) 75 mg/50 mg, 500 count (NDC 00378-1355-05) Reason for the Shortage • Watson could not provide a reason for the shortage. • Sandoz states the shortage is due to a raw material shortage and capacity issues. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=755 Source: www.ashp.org Sulfamethoxazole/Trimethoprim Injection March 12, 2012 Products Affected - Description Sulfamethoxazole 80 mg/trimethoprim 16 mg/mL injection, Teva 5 mL vial (NDC 00703-9503-03) 10 mL vial (NDC 00703-9514-03) 30 mL vial (NDC 00703-9526-01) Reason for the Shortage • Sulfamethoxazole/trimethoprim injection is on back order due to manufacturing problems and a recall. • Teva is the sole supplier of sulfamethoxazole/trimethoprim injection. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=613 Source: www.ashp.org Sterile Empty Vials March 12, 2012 Products Affected - Description Sterile Empty Vials, Hospira 10 mL, 50 count (List #05816-11) 30 mL, 50 count (List #05816-31) Empty Sterilized Vials, APP 5 mL, 25 count (NDC 63323-0001-05) 10 mL, 25 count (NDC 63323-0001-10) 30 mL, 25 count (NDC 63323-0001-30) 100 mL, 40 count (NDC 63323-0001-00) Reason for the Shortage • Hospira could not provide a reason for the shortage. • APP reduced production of sterile empty vials to permit increased production of drug products affected by critical shortages. • Sterile empty vials may be available from medical supply distributors. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=890 Source: www.ashp.org Indomethacin Injection March 12, 2012 Products Affected - Description 41
Page 1 and 2: April 2012 Drug Information Update
Page 3 and 4: First-Time Generics GENERIC DRUG NA
Page 5 and 6: GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39: Products Affected - Description Gan
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54: Ciprofloxacin Immediate-Release Tab
Page 55 and 56: • APP had tobramycin 40 mg/mL pre
Page 57 and 58: • Ben Venue voluntarily suspended
Page 59 and 60: 50 mg/mL, 10 mL vial, package of 10
Page 61 and 62: 2 mL vial, preservative-free (NDC 6
Page 63 and 64: 5 mg single dose vial, package of 1
Page 65 and 66: 20 mL glass ampule, sterile pack (N
Page 67 and 68: 2 mL iSecure syringe (NDC 00406-112
Page 69 and 70: Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72: • Teva discontinued all ciproflox
Page 73 and 74: Nicardipine hydrochloride injection
Page 75 and 76: Article link: http://www.ashp.org/D
Page 77 and 78: • Apotex had metformin products u
Page 79: • Covis purchased all rights to F

April 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?